Olson Jon A 4

What Happened
Jon A. Olson, a director of Rocket Lab Corp. (RKLB), sold a total of 15,205 shares in open-market transactions on January 20, 2026. The individual tranches ranged from 100 to 3,994 shares at prices reported between about $88.45 and $97.15, producing aggregate proceeds of approximately $1,388,222 (~$1.39M). The filing indicates these sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by Olson on September 19, 2025.

Key Details

• Transaction date: January 20, 2026; Form 4 filed January 22, 2026 (within the typical 2-business-day reporting window).
• Shares sold (by tranche/prices reported): 3,994 @ $89.02 (F2), 2,911 @ $90.03 (F3), 1,400 @ $90.75 (F4), 2,000 @ $92.08 (F5), 3,100 @ $92.81 (F6), 500 @ $93.78 (F7), 500 @ $94.99 (F8), 500 @ $96.13 (F9), 200 @ $97.00 (F10), 100 @ $97.92 (F10). Total: 15,205 shares; proceeds ≈ $1,388,222.
• Reported price ranges (per footnotes): roughly $88.45 to $97.15; several line items report weighted-average prices for multiple executions.
• Footnote F1: sales occurred automatically under a 10b5-1 trading plan adopted Sept 19, 2025. Other footnotes (F2–F10) detail that reported prices are weighted averages across multiple executions and offer to disclose per-trade prices on request.
• Shares owned after the transaction: not specified in the provided excerpt.

Context

• These were sales (not purchases), and because they were executed under an established 10b5-1 plan, they are typically considered pre-planned/automated rather than discretionary trades by the insider at the time of execution.
• Sales by directors are common and do not by themselves indicate company performance; purchases generally carry more weight as bullish signals.
• If you want the exact per-trade prices within the reported ranges, the filer has committed (via footnotes) to provide that breakdown to the company, shareholders, or the SEC upon request.